Soleno Therapeutics (SLNO) had the highest return last year by a mid-cap US stock, returning 1,825.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 2023 | 1,825.84% |
Cipher Mining (CIFR) | 2023 | 614.53% |
Marathon Digital (MARA) | 2023 | 556.15% |
QXO (QXO) | 2023 | 525.37% |
MoonLake Immunotherapeutics (MLTX) | 2023 | 469.72% |
Iris Energy (IREN) | 2023 | 445.8% |
CleanSpark (CLSK) | 2023 | 425.24% |
BridgeBio Pharma (BBIO) | 2023 | 418.89% |
Riot Blockchain (RIOT) | 2023 | 343.27% |
Dream Finders Homes (DFH) | 2023 | 301.47% |
Abercrombie & Fitch (ANF) | 2023 | 279.6% |
Oscar Health (OSCR) | 2023 | 266% |
Terawulf (WULF) | 2023 | 258.21% |
Applied Blockchain (APLD) | 2023 | 256.61% |
IONQ (IONQ) | 2023 | 247.06% |
Disc Medicine (IRON) | 2023 | 222.68% |
Hut 8 Corp Common Stock (HUT) | 2023 | 212.71% |
Camtek (CAMT) | 2023 | 211.96% |
Archer Aviation (ACHR) | 2023 | 211.68% |
SkyWest (SKYW) | 2023 | 210.9% |
Biohaven Pharmaceutical (BHVN) | 2023 | 204.63% |
Upstart Holdings (UPST) | 2023 | 200.88% |
Modine Manufacturing (MOD) | 2023 | 196.57% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2023 | 196.1% |
M/I Homes (MHO) | 2023 | 193.06% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
